NIVF Stock Overview
NewGenIvf Limited provides fertility services in Thailand, Cambodia, and Kyrgyzstan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
NewGenIvf Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.21 |
| 52 Week High | US$17.24 |
| 52 Week Low | US$0.64 |
| Beta | 0 |
| 1 Month Change | -59.80% |
| 3 Month Change | -88.98% |
| 1 Year Change | -88.48% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| NIVF | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -32.0% | -2.3% | 0.7% |
| 1Y | -88.5% | -0.01% | 23.9% |
Return vs Industry: NIVF underperformed the US Healthcare industry which returned 2.1% over the past year.
Return vs Market: NIVF underperformed the US Market which returned 24.2% over the past year.
Price Volatility
| NIVF volatility | |
|---|---|
| NIVF Average Weekly Movement | 48.8% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NIVF's share price has been volatile over the past 3 months.
Volatility Over Time: NIVF's weekly volatility has increased from 28% to 49% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | n/a | www.newgenivf.com |
NewGenIvf Limited provides fertility services in Thailand, Cambodia, and Kyrgyzstan. The company was founded in 2010 and is based in Central, Hong Kong.
NewGenIvf Group Limited Fundamentals Summary
| NIVF fundamental statistics | |
|---|---|
| Market cap | US$15.25m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs NIVF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NIVF income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did NIVF perform over the long term?
See historical performance and comparison